Table 4. Prevalence of liver enzyme alterations in the analyzed patient populations.

	ALT	AST	At least one (ALT,AST)	Both (ALT, AST)	GGT	At least one (ALT,AST,GGT)
MYH9 -RD	35/75 (46.7%)	32/75 (42.7%)	38/75 (50.7%)	29/75 (38.7%)	17/63 (27.0%)	39/69 (56.5%)
Other inherited thrombocytopenias	3/31 (9.7%)	1/30 (3.3%)	3/32 (9.4%)	1/29 (3.5%)	0/26 (0.0%)	3/26 11.5%)
ITP	5/77 (6.5%)	0/77 (0.0%)	5/77 (6.5%)	0/77 (0.0%)	4/71 (5.6%)	9/71 12.7%)
Ogliastra inhabitants	320/7257 (4.4%)	212/7257 (2.9%)	393/7257 (5.4%)	139/7257 (1.9%)	N.A.	N.A.

Data are presented as n° of patients with altered value/total n° of evaluable patients (%).

N.A. = not available.